🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07614854
Starting soon Observational

Effect of Prostatic Urethra and Seminal Vesicle Morphometry on Ejaculation

NCT07614854 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-05-10
Last updated
2026-06-03

Condition(s) studied

Premature EjaculationEjaculation

Study summary

The goal of this observational study is to learn whether the size and shape of the prostatic urethra and seminal vesicles - measured on multiparametric prostate MRI (mpMRI) - are related to premature ejaculation (PE) severity in men aged 18-55.

The main questions it aims to answer are:

* Do men with premature ejaculation have different prostatic urethral length and angulation compared to men without PE?
* Do men with premature ejaculation have different seminal vesicle dimensions compared to men without PE?
* Do prostatic urethra and seminal vesicle measurements on mpMRI correlate with PE severity scores (PEDT) and ejaculation latency time (IELT)?

Researchers will compare men with premature ejaculation to healthy men without ejaculatory complaints to see if specific anatomical features are associated with PE severity.

Participants will:

* Undergo a multiparametric prostate MRI that is already scheduled as part of their routine medical care
* Complete validated questionnaires about ejaculation and sexual function (PEDT, PEP, IELT, IIEF-15)
* Provide a blood sample for routine hormone level measurements

Eligibility

Sex
MALE
Min age
18 Years
Max age
55 Years
Healthy volunteers
Accepted
Inclusion Criteria: * \- Male aged 18 to 55 years * In a stable, heterosexual, monogamous relationship with the same female partner for at least 6 months * Normal erectile function defined as IIEF-15 erectile function domain score ≥26 * Scheduled for clinically indicated multiparametric prostate MRI due to elevated PSA or hematospermia * Not using any medication that may affect sexual function or psychological status (e.g., SSRIs, PDE5 inhibitors) Exclusion Criteria: * Any major psychiatric or somatic disorder * Hormonal disorders such as hypothyroidism or hyperthyroidism * Erectile dysfunction (IIEF-15 erectile function domain score \<26) * Age below 18 or above 55 years

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Başakşehir Çam and Sakura City Hospital, Department of Urology Istanbul Istanbul

More Başakşehir Çam & Sakura City Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07614854 on ClinicalTrials.gov ↗ ← All trials in Turkey